Bone Therapeutics S.A: Clinical Trials

11 trials sponsored by Bone Therapeutics S.A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 terminated, 1 unknown. 7 Phase 2, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Terminated 2, Unknown 1
Phase 34Completed 2, Terminated 2
Phase 11Completed 1

Follow Bone Therapeutics S.A: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture
ALLOB, placebo - Tibial Fracture
Phase 2UnknownBone Therapeutics S.A1782021-01-082021-06-07
Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis
JTA-004, Hylan G-F 20, placebo - Symptomatic Osteoarthritis of the Knee
Phase 3CompletedBone Therapeutics S.A7462020-03-102022-03-02
A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones
Delayed Union Fracture, CT-scan
CompletedBone Therapeutics S.A1732017-09-012020-06-11
A Study on Visco-antalgic Intra-articular Administration in Symptomatic Knee Osteoarthritis
JTA-004 intra-articular injection, Reference product intra-articular injection - Knee Osteoarthritis
Phase 2 / Phase 3CompletedBone Therapeutics S.A1732016-02-012021-12-06
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
Blood sampling - Rheumatoid Arthritis, Psoriatic Arthritis
TerminatedBone Therapeutics S.A302015-05-012020-06-11
Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion
ALLOB® cells with ceramic scaffold - Degenerative Disc Disease
Phase 2CompletedBone Therapeutics S.A382014-10-012021-01-29
Study on Allogeneic Osteoblastic Cells Implantation in Rescue Interbody Fusion
ALLOB® - Failed Lumbar Fusion
Phase 2TerminatedBone Therapeutics S.A62014-09-012020-06-11
Phase 1/2a Study on Allogeneic Osteoblastic Cells Implantation in Delayed-Union Fractures
ALLOB® implantation - Long Bone Delayed-Union Fracture
Phase 1 / Phase 2CompletedBone Therapeutics S.A252014-02-012021-11-10
Study on Autologous Osteoblastic Cells Implantation in Hypotrophic Non-Union Fractures
PREOB® Implantation, Bone Autograft - Long Bone Non-Union
Phase 2 / Phase 3TerminatedBone Therapeutics S.A52012-06-012020-06-11
Study on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head
Core decompression/PREOB® implantation, Core decompression/placebo implantation - Osteonecrosis of the Femoral Head
Phase 3TerminatedBone Therapeutics S.A682011-11-012022-06-24
Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head
Core decompression/PREOB® implantation, Core decompression/BMC implantation - Avascular Necrosis of Femur Head
Phase 2CompletedErasme University Hospital822003-10-012016-09-07

Conditions studied

Musculoskeletal Diseases (4)  ·  Fractures, Bone (3)  ·  Osteonecrosis (2)  ·  Arthritis (1)  ·  Arthritis, Psoriatic (1)  ·  Arthritis, Rheumatoid (1)  ·  Autoimmune Diseases (1)  ·  Femur Head Necrosis (1)  ·  Inflammation (1)  ·  Intervertebral Disc Degeneration (1)  ·  Legg-Calve-Perthes Disease (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)  ·  Pseudarthrosis (1)  ·  Rheumatic Diseases (1)

Interventions

Blood Specimen Collection (1)  ·  Saline Solution (1)

Countries

Belgium (6)  ·  Czechia (2)  ·  France (2)  ·  Germany (2)  ·  Poland (2)  ·  Denmark (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Moldova (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)

Results publications

PMID 34174963, PMID 34666767, PMID 36961220